This observational program collects data on tolerability, safety and efficacy regarding the
use of Abraxane in metastatic pancreatic cancer patients in the daily clinical routine.
Additionally data on dosage that is actually used in these patients will be collected.
Patients who have pancreatic cancer and additional diseases can be documented in this study,
too. Collected data might generate learnings on the optimal use of Abraxane in the daily
routine setting.